Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAPID
NCT07704359Phase 4Not yet recruiting
- Sponsor
- University of Illinois Chicago
- Start
- Oct 2026
- Primary completion
- Feb 2029
- Countries
- 1
01
Overview
A Phase 4 trial of amoxicillin, clavulanic acid, ciprofloxacin, metronidazole in anal fistula, perianal abscess, sponsored by University of Illinois Chicago. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
amoxicillinclavulanic acidciprofloxacinmetronidazole
03
Conditions
anal fistulaperianal abscess
Beyond the preview
Go deeper on NCT07704359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07704359.